Algenex CrisBio® platform validated by EU and UK marketing authorization for CrisBio-based apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
®
-based vaccine in major swine indication
Madrid (Spain) and Carros (France), February 22, 2021 – Algenex SL, a VC-backed biotechnology company delivering disruptive technologies for recombinant biologics production, and Virbac, the sixth largest animal health company worldwide, today announce that they have entered into an international licensing agreement for the development and commercialization of a CrisBio®-based vaccine in a major swine indication.
The vaccine will be developed jointly and manufactured using CrisBio®, Algenex proprietary and patent protected Baculovirus vector-mediated expression platform that harnesses the power of insects to act as natural single-use bioreactors. CrisBio® represents a new paradigm in biologics production, offering a quick, linearly scalable solution to meet the global demand for recombinant protein production without significant capex investment. Algenex anticipates receiving European approval of the first veterinary vaccine produ